ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646610 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646610; 2) Community: the network communities that were significantly associated with the response to NSC 646610; 3) Molecule: the relationships between components within communities and NSC 646610; 4) MDR: the compounds that were significantly associated with the NSC 646610.

NSC Compound Enrichment Correlation
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.046717891610184 0.30183059
NSC 747651 2-CHLORO-1-NITROSOPYRIDO[3',2':4,5]PYRROLO[1,2-C]BENZOTRIAZINE 0.046717891610184 0.3181056
NSC 667047 2-propenyl estradiol 0.0467178916101842 0.12420791
NSC 697685 Null 0.0467178916101842 0.083108617
NSC 698278 Null 0.0467178916101842 -0.069360237
NSC 706744 Indenoisoquinoline derivative 0.0467178916101842 0.11619626
NSC 727298 6-[(3-Thiomorpholyl)-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9 -methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0467178916101842 0.13666973
NSC 174121 Methotrexate Derivative 0.0467178916101845 0.042042236
NSC 181500 Null 0.0467178916101845 0.26055013
NSC 194350 Acridine Orange 0.0467178916101845 0.39874234
Total:101  Current:99    [First] [Prev] [Next] [Last]